227 related articles for article (PubMed ID: 25622979)
1. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
2. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
[TBL] [Abstract][Full Text] [Related]
3. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
[TBL] [Abstract][Full Text] [Related]
4. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
[TBL] [Abstract][Full Text] [Related]
5. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
6. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
7. MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells.
Botta C; Cucè M; Pitari MR; Caracciolo D; Gullà A; Morelli E; Riillo C; Biamonte L; Gallo Cantafio ME; Prabhala R; Mignogna C; Di Vito A; Altomare E; Amodio N; Di Martino MT; Correale P; Rossi M; Giordano A; Munshi NC; Tagliaferri P; Tassone P
Leukemia; 2018 Apr; 32(4):1003-1015. PubMed ID: 29158557
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA FOXD2‑AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway.
Huang P; Xue J
Int J Mol Med; 2020 Oct; 46(4):1477-1489. PubMed ID: 32945354
[TBL] [Abstract][Full Text] [Related]
9. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
11. A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells.
De Blasio A; Di Fiore R; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Scerri C; Vento R; Tesoriere G
J Cell Physiol; 2020 Feb; 235(2):629-637. PubMed ID: 31313842
[TBL] [Abstract][Full Text] [Related]
12. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
[TBL] [Abstract][Full Text] [Related]
13. In-silico and in-vitro evidence suggest LINC01405 as a sponge for miR-29b and miR-497-5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma.
Norouzi R; Mohamadzade Z; Norouzi R; Norouzi R; Esmaeili R; Soltani BM
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1972. PubMed ID: 38225865
[TBL] [Abstract][Full Text] [Related]
14. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in
Inoue A; Mizushima T; Wu X; Okuzaki D; Kambara N; Ishikawa S; Wang J; Qian Y; Hirose H; Yokoyama Y; Ikeshima R; Hiraki M; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2018 May; 17(5):977-987. PubMed ID: 29545333
[TBL] [Abstract][Full Text] [Related]
15. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
Zhang B; Shetti D; Fan C; Wei K
Biol Res; 2019 Jul; 52(1):38. PubMed ID: 31349873
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-κB signaling.
Senthil Kumar KJ; Gokila Vani M; Hsieh HW; Lin CC; Liao JW; Chueh PJ; Wang SY
Carcinogenesis; 2019 Apr; 40(2):335-348. PubMed ID: 30726934
[TBL] [Abstract][Full Text] [Related]
18. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
20. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
